Mr Ranan Dasgupta is a Consutlant Urologist at King Edward VII’s Hospital specialising in Prostate Disease, Kidney stones, Voiding dysfunction and Haematuria.
Mr Dasgupta has interests in comprehensive renal stone management and prevention, neuropathic bladder and urodynamics, novel treatments for Benign Prostate Hypertrophy, and Upper Tract Urothelial Cancer.
Since graduating from Cambridge University, with a thesis on Neuroanatomy (Corticospinal tract in the Primate), his MD thesis (Queen Square, UCL) focussed on Neural Mechanisms of Voiding; he has published over 50 peer-reviewed papers, including on Urodynamics and Fowler’s Syndrome, procured a prestigious Wellcome Trust project grant, and a Visiting Professorship to the Cleveland Clinic. Original descriptions of Botulinum toxin for neuropathic bladder, cannabinoids in Multiple Sclerosis, Sacral Nerve Stimulation for voiding dysfunction and Sildenafil for Female Sexual Dysfunction.
Since appointment at Imperial College Healthcare almost 10 years ago, he has been local Principal Investigator for 2 large national clinical urinary stone trials (TISU and PURE), and serves on the global SIU Endourology academic committee. He undertakes Lithotripsy (ESWL), Ureteroscopic laser treatment, and percutaneous stone surgery, as well as running a joint Metabolic stone clinic for recurrent stone formers.
In the field of BPH, he has been the local Principal Investigator for the UK registry of Prostate Artery Embolisation, as well as offering Urolift and HoLEP alternatives to TURP.
